Nexomics is an expert contract service provider offering accredited oncology laboratory assays to support clinical trials and medical testing.
Our dedicated state-of-the-art laboratories are located at the Peter MacCallum Cancer Centre, one of the world’s leading cancer research, education and treatment centres.
In the past 10 years our team has delivered 700+ clinical studies from Phases I to IV in all major oncology indications. Previous studies include involvement in early and late phase clinical trials for crizotinib (XALKORI) and vemurafenib (ZELBORAFREG).
Nexomics provides technical expertise for assessment of new diagnostic instrumentation against a “gold standard”. We offer a broad range of clinical tests for inclusion, safety monitoring, efficacy and exploratory biomarkers analysis using unparalleled access to clinical pathology samples.
Our services include: Anatomic Pathology, Molecular Pathology, Cancer Genomics, Flow Cytometry, Soluble marker analysis by ELISA and Luminex, sample processing and additional services such as sample logistics and bio-banking.
We welcome collaborations with pharma, biotech companies and clinical research organisations to engage in routine and customised laboratory testing.